The Art of the Possible: Reimagining the Biopharmaceutical Supply Chain

The Economist

On October 4, Dr. Anne Pritchett participated in a conversation with The Economist Impact during The Art of Possible: Reimagining the Biopharmaceutical Supply Chain. The group discussed the future of the biopharmaceutical supply chain and regulatory landscape, specifically the technology and policy changes needed to prepare the biopharmaceutical industry to succeed. Reflecting on lessons learned, the group strategized on how the industry can bring medicine to patients more efficiently, even amid future crises.


October 4, 2022, at 10 a.m. ET


  • Mike Douma, Vice-President, Supply Chain and Procurement, AbbVie
  • Tacy Foster, Partner, McKinsey
  • Meeta Gulyani, Head of Strategy, Business Development and Sustainability, Life Science, Merck
  • Alan Lovell, Senior Manager, Health, Policy, and Insights, Economist Impact
  • Anne McDonald Pritchett, Senior Vice-President, Policy and Research, PhRMA